Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Predictive model for high-frequency microsatellite instability in colorectal cancer patients over 50 years of age.

Fujiyoshi K, Yamaguchi T, Kakuta M, Takahashi A, Arai Y, Yamada M, Yamamoto G, Ohde S, Takao M, Horiguchi SI, Natsume S, Kazama S, Nishizawa Y, Nishimura Y, Akagi Y, Sakamoto H, Akagi K.

Cancer Med. 2017 Jun;6(6):1255-1263. doi: 10.1002/cam4.1088. Epub 2017 May 23.

2.

Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy.

Murcia O, Juárez M, Hernández-Illán E, Egoavil C, Giner-Calabuig M, Rodríguez-Soler M, Jover R.

World J Gastroenterol. 2016 Apr 7;22(13):3516-30. doi: 10.3748/wjg.v22.i13.3516. Review.

3.

Deficient mismatch repair: Read all about it (Review).

Richman S.

Int J Oncol. 2015 Oct;47(4):1189-202. doi: 10.3892/ijo.2015.3119. Epub 2015 Aug 12. Review.

4.

Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.

Weisenberger DJ, Levine AJ, Long TI, Buchanan DD, Walters R, Clendenning M, Rosty C, Joshi AD, Stern MC, Le Marchand L, Lindor NM, Daftary D, Gallinger S, Selander T, Bapat B, Newcomb PA, Campbell PT, Casey G, Ahnen DJ, Baron JA, Haile RW, Hopper JL, Young JP, Laird PW, Siegmund KD; , for the Colon Cancer Family Registry.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):512-9. doi: 10.1158/1055-9965.EPI-14-1161. Epub 2015 Jan 13.

5.

hMLH1 promoter methylation and BRAF mutations in high-frequency microsatellite instability colorectal cancers not fulfilling the revised Bethesda guidelines.

Kim SJ, Kim HR, Kim SH, Han JH, Cho YB, Yun SH, Lee WY, Kim HC.

Ann Surg Treat Res. 2014 Sep;87(3):123-30. doi: 10.4174/astr.2014.87.3.123. Epub 2014 Aug 26.

6.

Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer.

Kim JH, Kang GH.

World J Gastroenterol. 2014 Apr 21;20(15):4230-43. doi: 10.3748/wjg.v20.i15.4230. Review.

7.

New genes emerging for colorectal cancer predisposition.

Esteban-Jurado C, Garre P, Vila M, Lozano JJ, Pristoupilova A, Beltrán S, Abulí A, Muñoz J, Balaguer F, Ocaña T, Castells A, Piqué JM, Carracedo A, Ruiz-Ponte C, Bessa X, Andreu M, Bujanda L, Caldés T, Castellví-Bel S.

World J Gastroenterol. 2014 Feb 28;20(8):1961-71. doi: 10.3748/wjg.v20.i8.1961. Review.

8.

Utility of MLH1 methylation analysis in the clinical evaluation of Lynch Syndrome in women with endometrial cancer.

Bruegl AS, Djordjevic B, Urbauer DL, Westin SN, Soliman PT, Lu KH, Luthra R, Broaddus RR.

Curr Pharm Des. 2014;20(11):1655-63.

9.

Epigenetics meets radiation biology as a new approach in cancer treatment.

Kim JG, Park MT, Heo K, Yang KM, Yi JM.

Int J Mol Sci. 2013 Jul 18;14(7):15059-73. doi: 10.3390/ijms140715059. Review.

10.
11.

Family history of colorectal cancer in BRAF p.V600E-mutated colorectal cancer cases.

Buchanan DD, Win AK, Walsh MD, Walters RJ, Clendenning M, Nagler B, Pearson SA, Macrae FA, Parry S, Arnold J, Winship I, Giles GG, Lindor NM, Potter JD, Hopper JL, Rosty C, Young JP, Jenkins MA.

Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):917-26. doi: 10.1158/1055-9965.EPI-12-1211. Epub 2013 Mar 5.

12.

A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry.

Thompson BA, Goldgar DE, Paterson C, Clendenning M, Walters R, Arnold S, Parsons MT, Michael D W, Gallinger S, Haile RW, Hopper JL, Jenkins MA, Lemarchand L, Lindor NM, Newcomb PA, Thibodeau SN; Colon Cancer Family Registry, Young JP, Buchanan DD, Tavtigian SV, Spurdle AB.

Hum Mutat. 2013 Jan;34(1):200-9. doi: 10.1002/humu.22213. Epub 2012 Oct 11.

13.

MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study.

Gausachs M, Mur P, Corral J, Pineda M, González S, Benito L, Menéndez M, Espinàs JA, Brunet J, Iniesta MD, Gruber SB, Lázaro C, Blanco I, Capellá G.

Eur J Hum Genet. 2012 Jul;20(7):762-8. doi: 10.1038/ejhg.2011.277. Epub 2012 Jan 25.

14.

A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome.

Boparai KS, Dekker E, Polak MM, Musler AR, van Eeden S, van Noesel CJ.

Am J Pathol. 2011 Jun;178(6):2700-7. doi: 10.1016/j.ajpath.2011.02.023.

15.

CpG island methylation in colorectal cancer: past, present and future.

Curtin K, Slattery ML, Samowitz WS.

Patholog Res Int. 2011 Apr 12;2011:902674. doi: 10.4061/2011/902674.

16.

Molecular profiling of colon tumors: the search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predisposition.

Bacolod MD, Barany F.

Ann Surg Oncol. 2011 Dec;18(13):3694-700. doi: 10.1245/s10434-011-1615-5. Epub 2011 Feb 24. Review.

17.

DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset.

Berg M, Danielsen SA, Ahlquist T, Merok MA, Ågesen TH, Vatn MH, Mala T, Sjo OH, Bakka A, Moberg I, Fetveit T, Mathisen Ø, Husby A, Sandvik O, Nesbakken A, Thiis-Evensen E, Lothe RA.

PLoS One. 2010 Nov 12;5(11):e13978. doi: 10.1371/journal.pone.0013978.

18.

Cigarette smoking and colorectal cancer risk by molecularly defined subtypes.

Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, Lynch CF, Anderson KE, French AJ, Haile RW, Harnack LJ, Potter JD, Slager SL, Smyrk TC, Thibodeau SN, Cerhan JR, Limburg PJ.

J Natl Cancer Inst. 2010 Jul 21;102(14):1012-22. doi: 10.1093/jnci/djq201. Epub 2010 Jun 29.

19.

Colorectal cancer: molecular features and clinical opportunities.

Worthley DL, Leggett BA.

Clin Biochem Rev. 2010 May;31(2):31-8.

20.

De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one.

Goel A, Nguyen TP, Leung HC, Nagasaka T, Rhees J, Hotchkiss E, Arnold M, Banerji P, Koi M, Kwok CT, Packham D, Lipton L, Boland CR, Ward RL, Hitchins MP.

Int J Cancer. 2011 Feb 15;128(4):869-78. doi: 10.1002/ijc.25422.

Supplemental Content

Support Center